Announcements Trials

Browse Landscape

Status

Active not recruiting 2 Withdrawn 1 Unknown 1 Terminated 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1

Interventions

pembrolizumab 185 Carboplatin 131 Paclitaxel 123 Gemcitabine 122 Docetaxel 97 Cyclophosphamide 89 Nivolumab 88 Cisplatin 87 Rituximab 71 Dexamethasone 68 Pemetrexed 65 Bevacizumab 65 Capecitabine 60 atezolizumab 55 fludarabine 49 Fluorouracil 49 Azacitidine 49 130-nm albumin-bound paclitaxel 43 Irinotecan 42 venetoclax 41 Trastuzumab 41 Cetuximab 40 Leucovorin 37 Ipilimumab 36 Erlotinib Hydrochloride 35 Oxaliplatin 32 Fulvestrant 32 Cytarabine 32 avelumab 31 Albumin-Bound Paclitaxel 31

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × INDUSTRY × Biopsy, Large-Core Needle × Clear all

NCT05435352 2025-07-30

PEAR-TNBC

Ourotech, Inc.

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡